EMPLOYMENT AGREEMENTEmployment Agreement • September 20th, 2005 • Innovive Pharmaceuticals, Inc. • New York
This Agreement (this “Agreement”), dated as of March 4, 2005 (sometimes the “Effective Date”), by and between INNOVIVE PHARMACEUTICALS, INC., a Delaware corporation with principal executive offices at 787 Seventh Avenue, 48th Floor, New York, NY 10019 (the “Company”), and ERIC POMA, residing at 165 Christopher Street, #4I, New York New York 10014 (the “Executive”).
Portions of this exhibit marked [*] are omitted and are requested to be treated confidentially. INDUSTRY-UNIVERSITY COOPERATIVE RESEARCH AGREEMENTIndustry-University Cooperative Research Agreement • September 20th, 2005 • Innovive Pharmaceuticals, Inc. • Pennsylvania
THIS AGREEMENT, effective this 16th day of March 2005, by and between The Pennsylvania State University College of Medicine and The Milton S. Hershey Medical Center (hereinafter referred to collectively as "University") and INNOVIVE Pharmaceuticals, Inc., (hereinafter referred to as "Contractor").
Portions of this exhibit marked [*] are requested to be treated confidentially. LICENSE AGREEMENTLicense Agreement • September 20th, 2005 • Innovive Pharmaceuticals, Inc. • Pennsylvania
This License Agreement, effective upon the date of last signature herein (the "Effective Date"), by and between The Penn State Research Foundation (hereinafter referred to as "PSRF"), a non-profit corporation duly organized and existing under the laws of the Commonwealth of Pennsylvania and having an office at 304 Old Main, University Park, PA 16802, and INNOVIVE Pharmaceuticals, Inc. a corporation organized under the laws of the State of Delaware (hereinafter referred to as "LICENSEE"), having its principal office at 787 Seventh Avenue, 48th Floor, New York, New York 10019.
NOTE AND WARRANT PURCHASE AGREEMENTNote and Warrant Purchase Agreement • September 20th, 2005 • Innovive Pharmaceuticals, Inc. • New York
This NOTE AND WARRANT PURCHASE AGREEMENT (this “Agreement”) made as of the date set forth on the signature page hereof between Innovive Pharmaceuticals, Inc., a Delaware corporation having its principal place of business at 555 Madison Avenue, 25th Floor, New York, NY 10022 (the “Company”), and the undersigned (the “Subscriber”).
SUBLEASESublease • September 20th, 2005 • Innovive Pharmaceuticals, Inc. • New York
Notwithstanding anything in this Sublease to the contrary, Sublandlord agrees to cooperate with Subtenant, at no cost or expense to Sublandlord other than those costs or expenses paid by Subtenant, in (i) obtaining for Subtenant any consent of Master Landlord sought by Subtenant for any action for which the Master Lease requires Master Landlord’s consent and (ii) delivering any notice to Master Landlord as required by any provision of the Master Lease including, without limitation, promptly forwarding any request made by Subtenant to Master Landlord for services, or consent or approval, and upon receipt from Subtenant, providing Master Landlord with all information required (or that Master Landlord may reasonably request) regarding such request. In the event Subtenant shall obtain the consent of Master Landlord with respect to a matter requiring the consent of Master Landlord under the Master Lease, then provided such matter does not impose any additional obligation, duty or liability
